TOP TIERMARKET NEWSWIRE

News & sentiment

TAKEDA PHARMACEUTICA A ADR (TAK) — News & AI sentiment

TAKEDA PHARMACEUTICA A ADR (TAK) news roundup. 1 story in the past week, 13 over 30 days. Average 30-day sentiment is 66.7/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 18 sales totalling $12.4M — net selling of $12.4M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

1

avg sentiment 63/100

30d stories

13

avg sentiment 66.7/100

Insider net (90d)

$12.4M

0 buys · 18 sells

Congress (90d)

0

0 buys · 0 sells

TAK news in the last 24 hours, 7 days, 30 days and 90 days

How much TAK coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	TAK stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	1	63/100	TAK headlines →
Last 30 days	13	66.7/100	TAK headlines →
Last 90 days	48	61.3/100	TAK headlines →

Latest stories on TAK

Takeda announces publication of data from Phase 3 studies of oveporexton

The Fly63 · neutralproduct/pr

4d ago

Bulls Take Control of Takeda Pharmaceuticals: Chart of the Day

Barron's63 · neutralanalyst

Sep 4

Bayer, Takeda expected to announce new pricing deals with White House, FT says

The Fly54 · neutralgeneral

Aug 31

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

The Fly73 · bullishproduct/pr

Aug 30

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

TipRanks73 · bullishproduct/pr

Aug 29

Takeda receives FDA approval of NDA for Mimrylo

The Fly72 · bullishproduct/pr

Aug 28

Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera

StockTitan73 · bullishproduct/pr

Aug 28

Takeda gains approval of rusfertide for polycythemia vera

Seeking Alpha73 · bullishproduct/pr

Aug 28

Novavax announces regulatory approvals for updated COVID shot

Seeking Alpha67 · bullishproduct/pr

Aug 28

Takeda announces Japan MHLW approval for Orzeyful

The Fly65 · bullishproduct/pr

Aug 24

Silence Therapeutics: Making Some Recent Noise

Seeking Alpha63 · neutralproduct/pr

Aug 19

Moving at the speed of pharma digitalisation: driving ROI from AI and digital tools

Yahoo Finance55 · neutralgeneral

Aug 17

Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?

Yahoo Top73 · bullishproduct/pr

Aug 14

Takeda award from Veterans Affairs posted to SAM.gov site

The Fly50 · neutralgeneral

Aug 10

Takeda (TAK) Q1 2026 Earnings Call Transcript

The Motley Fool63 · neutralearnings

Aug 8

Takeda’s Brazil IBD Study Wraps Up, Offering Fresh Clues on Vedolizumab Performance

TipRanks55 · neutralgeneral

Aug 7

Takeda's Pipeline Looks Encouraging, But Generic Erosion Is A Near-Term Concern

Seeking Alpha54 · neutralgeneral

Aug 7

Takeda’s FDA Approval for ORZEYFUL Sets a New Standard in Narcolepsy Type 1 Care August 6, 2026

MarketChameleon78 · bullishproduct/pr

Aug 6

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1

StockTitan73 · bullishproduct/pr

Aug 5

Takeda wins approval of narcolepsy drug oveporexton

Seeking Alpha73 · bullishproduct/pr

Aug 5

Takeda Pharmaceutical Company Limited (TAK) Q1 2026 Earnings Call Transcript

Seeking Alpha52 · neutralearnings

Aug 4

Keros Therapeutics to Receive $20 Million Development Milestone Payment From Takeda

Morningstar73 · bullishproduct/pr

Jul 30

Takeda Pharmaceutical Company Limited (TAK) Q1 2027 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Jul 30

Takeda Pharmaceutical Q1 Earnings Call Highlights

Yahoo Finance56 · neutralearnings

Jul 30

Takeda Pharmaceutical Company Limited 2027 Q1 - Results - Earnings Call Presentation

Seeking Alpha50 · neutralearnings

Jul 30

Open TAK in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →